The global clinical trial biorepository & archiving solutions market size was valued at USD 7.0 billion in 2030 and is projected to grow at a CAGR of 8.17% from 2024 to 2030, according to a new report. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth. ![Clinical Trial Biorepository & Archiving Solutions Market]( "Clinical Trial Biorepository & Archiving Solutions Market")
Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).
The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.
Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).
The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.
Clinical Trial Biorepository & Archiving Solutions Market Report Highlights
- The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
- In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
- The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
- Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Product
1.2.3. Phase
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
1.12. Objectives
1.2. Segment Definitions
1.2.1. Service
1.2.2. Product
1.2.3. Phase
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
1.12. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing number of pharmaceutical and biotechnology companies
3.2.1.2. Growing disease variation and prevalence
3.2.1.3. Increasing R&D investments
3.2.1.4. Growth in the CRO market
3.2.2. Market Restraint Analysis
3.2.2.1. Regulations for new drug development
3.2.2.2. Rising cost of clinical trials
3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing number of pharmaceutical and biotechnology companies
3.2.1.2. Growing disease variation and prevalence
3.2.1.3. Increasing R&D investments
3.2.1.4. Growth in the CRO market
3.2.2. Market Restraint Analysis
3.2.2.1. Regulations for new drug development
3.2.2.2. Rising cost of clinical trials
3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis
4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
4.3.1. Biorepository Services
4.3.1.1. Biorepository Services Market, 2018 to 2030 (USD Million)
4.3.1.2. Warehousing & storage
4.3.1.2.1. Warehousing & storage Market, 2018 to 2030 (USD Million)
4.3.1.3. Transportation
4.3.1.3.1. Transportation Market, 2018 to 2030 (USD Million)
4.3.1.4. Sample Processing
4.3.1.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
4.3.1.5. Others Biorepository Services
4.3.1.5.1. Others Biorepository Services Market, 2018 to 2030 (USD Million)
4.3.2. Archiving Solution Services
4.3.2.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
4.3.2.2. Database Indexing and Management
4.3.2.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
4.3.2.3. Scanning & Destruction
4.3.2.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)
4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
4.3.1. Biorepository Services
4.3.1.1. Biorepository Services Market, 2018 to 2030 (USD Million)
4.3.1.2. Warehousing & storage
4.3.1.2.1. Warehousing & storage Market, 2018 to 2030 (USD Million)
4.3.1.3. Transportation
4.3.1.3.1. Transportation Market, 2018 to 2030 (USD Million)
4.3.1.4. Sample Processing
4.3.1.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
4.3.1.5. Others Biorepository Services
4.3.1.5.1. Others Biorepository Services Market, 2018 to 2030 (USD Million)
4.3.2. Archiving Solution Services
4.3.2.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
4.3.2.2. Database Indexing and Management
4.3.2.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
4.3.2.3. Scanning & Destruction
4.3.2.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)
Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis
5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product Type, 2018 - 2030
5.3.1. Preclinical Products
5.3.1.1. Preclinical Products Market, 2018 to 2030 (USD Million)
5.3.2. Clinical Products
5.3.2.1. Clinical Products Market, 2018 to 2030 (USD Million)
5.3.2.2. Human Tissue
5.3.2.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
5.3.2.3. Organs
5.3.2.3.1. Organs Market, 2018 to 2030 (USD Million)
5.3.2.4. Stem Cells
5.3.2.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
5.3.2.5. Other Biospecimens
5.3.2.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)
5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product Type, 2018 - 2030
5.3.1. Preclinical Products
5.3.1.1. Preclinical Products Market, 2018 to 2030 (USD Million)
5.3.2. Clinical Products
5.3.2.1. Clinical Products Market, 2018 to 2030 (USD Million)
5.3.2.2. Human Tissue
5.3.2.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
5.3.2.3. Organs
5.3.2.3.1. Organs Market, 2018 to 2030 (USD Million)
5.3.2.4. Stem Cells
5.3.2.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
5.3.2.5. Other Biospecimens
5.3.2.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)
Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis
6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
6.3.1. Preclinical
6.3.1.1. Preclinical Market, 2018 to 2030 (USD Million)
6.3.2. Phase I
6.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
6.3.3. Phase II
6.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
6.3.4. Phase III
6.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
6.3.5. Phase IV
6.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)
6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
6.3.1. Preclinical
6.3.1.1. Preclinical Market, 2018 to 2030 (USD Million)
6.3.2. Phase I
6.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
6.3.3. Phase II
6.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
6.3.4. Phase III
6.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
6.3.5. Phase IV
6.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)
Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. North America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. Europe Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Scenario
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Scenario
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Scenario
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Scenario
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Scenario
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Scenario
7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Scenario
7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Scenario
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Scenario
7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Scenario
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Scenario
7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Scenario
7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Scenario
7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Scenario
7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Scenario
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Scenario
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
7.8. MEA
7.8.1. MEA Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Scenario
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Scenario
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Scenario
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Scenario
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. North America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. Europe Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Scenario
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Scenario
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Scenario
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Scenario
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Scenario
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Scenario
7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Scenario
7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Scenario
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Scenario
7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Scenario
7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Scenario
7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Scenario
7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Scenario
7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Scenario
7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Scenario
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Scenario
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
7.8. MEA
7.8.1. MEA Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Scenario
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Scenario
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Scenario
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Scenario
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2023
8.2. Company Profiles
8.2.1. Medpace
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Service Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. American Type Culture Collection (ATCC)
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Service Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Cell&Co BioServices (Cryoport)
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Service Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Brooks Life Sciences (Azenta, Inc.)
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Service Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Patheon (Thermo Fisher Scientific, Inc.)
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Service Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Precision Medicine Group, LLC.
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Service Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Labcorp Drug Development
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Service Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Q2 Solutions
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Service Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. LabConnect
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Service Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Charles River Laboratories
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Service Benchmarking
8.2.10.4. Strategic Initiatives
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2023
8.2. Company Profiles
8.2.1. Medpace
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Service Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. American Type Culture Collection (ATCC)
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Service Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Cell&Co BioServices (Cryoport)
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Service Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Brooks Life Sciences (Azenta, Inc.)
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Service Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Patheon (Thermo Fisher Scientific, Inc.)
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Service Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Precision Medicine Group, LLC.
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Service Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Labcorp Drug Development
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Service Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Q2 Solutions
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Service Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. LabConnect
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Service Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Charles River Laboratories
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Service Benchmarking
8.2.10.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 4. North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 5. North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 6. North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 7. U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 8. U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 9. U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 10. Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 11. Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 12. Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 13. Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 14. Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 15. Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 16. Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 17. UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 18. UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 19. UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 20. Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 21. Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 22. Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 23. France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 24. France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 25. France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 26. Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 27. Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 28. Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 29. Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 30. Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 31. Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 32. Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 33. Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 34. Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 35. Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 36. Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 37. Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 38. Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 39. Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 40. Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 41. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 42. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 43. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 44. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 45. Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 46. Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 47. Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 48. China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 49. China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 50. China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 51. India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 52. India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 53. India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 54. Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 55. Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 56. Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 57. South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 58. South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 59. South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 60. Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 61. Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 62. Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 63. Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 64. Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 65. Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 66. Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 67. Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 68. Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 69. Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 70. Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 71. Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 72. Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 73. Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 74. Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 75. Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 76. Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 77. Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 78. Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 79. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 83. South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 84. South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 85. South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 89. UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 90. UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 91. UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 92. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 93. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 94. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 2. List of Abbreviations
Table 3. North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 4. North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 5. North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 6. North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 7. U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 8. U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 9. U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 10. Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 11. Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 12. Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 13. Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 14. Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 15. Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 16. Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 17. UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 18. UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 19. UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 20. Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 21. Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 22. Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 23. France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 24. France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 25. France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 26. Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 27. Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 28. Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 29. Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 30. Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 31. Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 32. Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 33. Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 34. Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 35. Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 36. Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 37. Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 38. Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 39. Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 40. Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 41. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 42. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 43. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 44. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 45. Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 46. Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 47. Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 48. China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 49. China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 50. China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 51. India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 52. India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 53. India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 54. Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 55. Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 56. Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 57. South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 58. South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 59. South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 60. Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 61. Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 62. Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 63. Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 64. Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 65. Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 66. Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 67. Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 68. Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 69. Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 70. Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 71. Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 72. Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 73. Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 74. Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 75. Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 76. Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 77. Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 78. Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 79. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 83. South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 84. South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 85. South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 89. UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 90. UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 91. UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
Table 92. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
Table 93. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
Table 94. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Clinical trial biorepository & archiving solutions market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot 1
Fig. 13 Segment snapshot 2
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market outlook, 2023 (USD Billion)
Fig. 16 Ancillary market outlook, 2023 (USD Billion)
Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
Fig. 18 Porter’s five forces analysis
Fig. 19 PESTEL analysis
Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Regional Marketplace: Key Takeaways
Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Fig. Key country dynamics
Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key company categorization
Fig. 100 Service heat map analysis
Fig. 101 Strategic framework
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot 1
Fig. 13 Segment snapshot 2
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market outlook, 2023 (USD Billion)
Fig. 16 Ancillary market outlook, 2023 (USD Billion)
Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
Fig. 18 Porter’s five forces analysis
Fig. 19 PESTEL analysis
Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Regional Marketplace: Key Takeaways
Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Fig. Key country dynamics
Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key company categorization
Fig. 100 Service heat map analysis
Fig. 101 Strategic framework
Companies Mentioned
- Medpace
- American Type Culture Collection (ATCC)
- Cell&Co BioServices (Cryoport)
- Brooks Life Sciences (Azenta, Inc.)
- Patheon (Thermo Fisher Scientific, Inc.)
- Precision Medicine Group, LLC.
- Labcorp Drug Development
- Q2 Solutions
- LabConnect
- Charles River Laboratories
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 192 |
| Published | July 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 4 Billion |
| Forecasted Market Value ( USD | $ 7 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
